680199-29-5

Upstream product

• 42747-54-6 2-chloro-3,5-dinitrobenzoyl chloride 
• 141-43-5 ethanolamine 

Downstream Products

• 1012063-63-6 2-[(2-bromoethyl)amino]-N-(2-hydroxyethyl)-3,5-dinitrobenzamide 
• 851627-59-3 2-[N-(2-chloroethyl)-2-(6-tert-butoxy-8,8-dimethyl-6-oxido-5,7-dioxa-2-aza-6-phosphanon-1-anoyl)-4,6-dinitroanilino]ethyl methanesulfonate 
• 944088-77-1 di(tert-butyl) 2-({2-[(2-chloroethyl)(2-hydroxyethyl)amino]-3,5-dinitrobenzoyl}amino)ethyl phosphate 
• 944088-64-6 di(tert-butyl) 2-[(2-chloro-3,5-dinitrobenzoyl)amino]ethyl phosphate 

Relevant academic research and scientific papers

NOVEL NITROPHENYL MUSTARD AND NITROPHENYLAZIRIDINE ALCOHOLS AND THEIR CORRESPONDING PHOSPHATES AND THEIR USE AS TARGETED CYTOTOXIC AGENTS

The present invention relates to novel nitrophenyl mustard and nitrophenylaziridine alcohols, to their corresponding phosphates, to their use as targeted cytotoxic agents; as bioreductive drugs in hypoxic tumours, and to their use in cell ablation, includ

NITROANILINE-BASED ALKYLATING AGENTS AND THEIR USE AS PRODRUGS

Nitroaniline-based unsymmetrical mustards of the general formula (I) are provided, together with methods of preparation and methods for their use as produgs for gene-dependent enzyme prodrug therapy (GDEPT) and cell ablation therapy in conjuction with nit